The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Examining two hematologic precursors and their impact on incident lymphoid malignancies.
 
Nicholas J. Boddicker
No Relationships to Disclose
 
Rosalie Griffin
No Relationships to Disclose
 
Erin G Franke
No Relationships to Disclose
 
Sara J Achenbach
No Relationships to Disclose
 
Kari G. Rabe
No Relationships to Disclose
 
Janet E. Olson
Research Funding - Exact Sciences
 
Daniel R O'Brien
No Relationships to Disclose
 
Aaron Norman
No Relationships to Disclose
 
Tao Ma
No Relationships to Disclose
 
Timothy G. Call
No Relationships to Disclose
 
Mingma S Hoel
No Relationships to Disclose
 
Esteban Braggio
No Relationships to Disclose
 
Paul Joseph Hampel
No Relationships to Disclose
 
Curtis A Hanson
No Relationships to Disclose
 
James Robert Cerhan
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); Protagonist Therapeutics
Research Funding - Celgene (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genmab (Inst); NanoString Technologies (Inst)
(OPTIONAL) Uncompensated Relationships - Regeneron (Inst)
 
Celine M. Vachon
No Relationships to Disclose
 
Sameer Ashok Parikh
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Janssen (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); NovalGen (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Research Funding - Ascentage Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Janssen (Inst); Merck (Inst); TG Therapeutics (Inst)
 
Tait D. Shanafelt
Research Funding - Celgene (Inst); Cephalon (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Hospira (Inst); Pharmacyclics (Inst); Polyphenon E International (Inst)
Patents, Royalties, Other Intellectual Property - Dr. Shanafelt is co-inventor of the Well-being Index Instruments (Physician Well-being Index; Nurse Well-being Index; Medical Student Well-being Index; Well-being Index) and the Mayo Clinic Participatory Management Leadership Index. Mayo Clinic holds the
Other Relationship - Medical Center
 
Susan L. Slager
No Relationships to Disclose